Detalles de la búsqueda
1.
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer.
Cytopathology
; 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822635
2.
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Crit Rev Oncol Hematol
; 193: 104220, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38036154
3.
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
Ther Adv Med Oncol
; 15: 17588359231151845, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36818688
4.
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Cancer Treat Rev
; 121: 102650, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37939446
5.
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.
Crit Rev Oncol Hematol
; 172: 103626, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35150867
6.
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study.
Cancers (Basel)
; 14(23)2022 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497493
7.
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
Crit Rev Oncol Hematol
; 170: 103597, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033663
8.
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.
Cancers (Basel)
; 15(1)2022 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612211
9.
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
Front Oncol
; 11: 682445, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178674
10.
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
Ther Adv Med Oncol
; 13: 17588359211049779, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616493
11.
Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?
Oncol Res Treat
; 43(10): 526-530, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32772025
12.
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Cancers (Basel)
; 12(9)2020 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854451
13.
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.
Cancers (Basel)
; 12(5)2020 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380732
14.
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
Cancers (Basel)
; 12(11)2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33207823
15.
Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival.
Mediterr J Hematol Infect Dis
; 12(1): e2020008, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31934318
16.
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis.
Cancers (Basel)
; 12(3)2020 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32110977
17.
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients.
Ther Adv Med Oncol
; 12: 1758835920975326, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403015
18.
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.
Transl Cancer Res
; 8(Suppl 1): S55-S63, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117064
19.
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
Adv Ther
; 36(10): 2600-2617, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31432460
Resultados
1 -
19
de 19
1
Próxima >
>>